1389 (1389) Fair Value & Analysis

Consumer Defensive · Market cap HK$249M

1 1389 1389 · HK

PriceHK$0.4450

Fair ValueHK$0.1900

Upside-57.3%

Quality60/100

Watch 1389 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.1300 – HK$0.2400

Fair value as of: Jul 2, 2026

From 1 valuation models · updated yesterday

Share price −24.1% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2326 – HK$0.7889 · fair‑value band HK$0.1300 – HK$0.2400 · the HK$0.4450 price screens above the HK$0.1900 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1389 (1389) currently trades at HK$0.4450, while our model-based Fair Value estimate is HK$0.1900 — implying the stock looks roughly 57.3% overvalued today. We read business quality at 60/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 1389 generated revenue of HK$52.8M at a net margin of -3.5%. Revenue grew 27.3% year over year. It earns a return on equity of -1.7%. The balance sheet holds a net cash position of HK$4.2M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$52.8M

Revenue growth (YoY) +27.3%

Net margin -3.5%

Return on equity -1.7%

Free cash flow −HK$5.3M FY2026

Operating margin -2.5%

More key figures

Net cash HK$4.2M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

1389 reported revenue of HK$52.8M in FY2026 versus HK$108M in FY2022, a compound −16.4%/yr. Reported net income was −HK$1.9M in FY2026.

Revenue −16.4%/yr

FY22 HK$108M

FY23 HK$74.4M

FY24 HK$63.0M

FY25 HK$58.0M

FY26 HK$52.8M

Net income

FY22 −HK$8.7M

FY23 −HK$16.6M

FY24 −HK$15.7M

FY25 −HK$13.4M

FY26 −HK$1.9M

Is 1389 fairly valued? → Check now

Similar stocks

6 more Beverages - Wineries & Distilleries stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Kweichow Moutai Co 600519	¥1,273	¥800.18	-37%
Wuliangye Yibin Co 000858	¥79.14	¥45.59	-42%
Diageo plc DEO	$81.79	$44.14	-46%
Shanxi Xinghuacun Fen Wine Factory Co 600809	¥118.79	¥159.08	+34%
Luzhou Laojiao Co 000568	¥86.88	¥95.88	+10%
Pernod Ricard SA PDRDF	$73.05	$68.07	-7%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1389 (1389) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.1900 versus a price of HK$0.4450 — about −57% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1389?

Our model-based fair value for 1389 is HK$0.1900 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.4450.

What is the quality score of 1389?

1389 has a Quality Score of 60/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1389 (1389)?

1389 reported trailing-twelve-month revenue of about HK$52.8M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1389?

The net profit margin of 1389 is about -3.5%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.